Expert storytelling turned into global thought leadership.

CooperVision built a global thought leadership program with zero paid promotion — enabling clinical and commercial subject matter experts to tell their own stories and drive organic engagement from the global eye care community.

Clinical credibility invisible to the market.

CooperVision is one of the world's largest contact lens manufacturers — with clinical researchers, optometrists, and commercial specialists whose expertise is among the most advanced in the field, including the MiSight® 1 day lens, the first FDA-approved soft contact lens clinically proven to slow myopia progression in children. But that expertise lived in conference presentations and internal briefings, not in the channels where eye care professionals actually discover new ideas.

Expert-owned narratives drive engagement.

At the International Myopia Conference 2024, CooperVision identified an opportunity to extend influence by enabling experts to tell their own stories. MarketScale structured a content program around CooperVision's clinical and commercial leaders — capturing interviews, conference moments, and industry insights from the personal profiles of the practitioners themselves. Each piece was produced to meet the standards eye care professionals expect from clinical communication.

Global reach. Earned credibility. Zero ad spend.

CooperVision's thought leadership content reached eye care professionals across global markets — through LinkedIn, professional networks, and direct sales enablement — driven entirely by authentic first-person expert stories. Every impression was earned. The program established CooperVision's clinical team as visible, credible voices in the global eye care conversation and reinforced business positioning in a market projected to grow from $9.92B to $13.1B by 2030.